Plymouth University chooses Brain Tumour Research as official charity

August 20, 2014

Brain Tumour Research has been chosen by Plymouth University to be an official charity partner. Brain Tumour Research was launched in April 2009 to raise awareness of, and funding for, scientific research into brain tumours and improve outcomes for brain tumour patients.

A range of events and activities organised by the University will raise funds for the charity, and members of staff and students, as well as other University partners, will be encouraged to donate, fundraise and volunteer. The involvement of the wider community across the South West will also be important.

Earlier this year Brain Tumour Research chose Plymouth University Peninsula Schools of Medicine and Dentistry to join its growing network of Research Centres of Excellence. The team in Plymouth were recognised for their international reputation for research in the uniquely challenging field of low grade brain tumours and tumours of the nervous system - many of which affect the young. Researchers in Plymouth are fast tracking drug therapies with a view to making them available to patients quickly and safely

The research team works closely with clinicians at Plymouth Hospital NHS Trust, which is a regional centre for brain tumour treatment and care.

More children and adults under 40 die of a brain tumour than from any other cancer, yet brain tumours receive just one per cent of the national spend on cancer research. Currently the treatments available are complex and hazardous surgery to remove the tumour and radiotherapy or chemotherapy. Despite the advances in science and the growing opportunities for neurological investigation unless we significantly increase research funding it could take another 100 years to find a cure.

Money raised across the region help towards funding research at the Brain Tumour Research Centre of Excellence at Plymouth University.

Brain Tumour Research is on a mission to raise £7 million per year in order to support their four Research Centres of Excellence and establish three more.

Professor David Coslett, Deputy Vice-Chancellor, Plymouth University said: "As world leaders in brain tumour research it is only right that we make Brain Tumour Research an official charity partner. We are starting out on an exciting journey with the charity which will see us together raise awareness of brain tumours, embark on some exciting fundraising activities and ultimately contribute to better therapies for patients - we firmly believe that our work holds the key to better, more effective treatments for this type of brain tumour in the future. We hope that the people of the South West will work with us to make this partnership a huge success."

Sue Farrington Smith, Chief Executive of Brain Tumour Research added: "Brain tumours are the biggest cancer killer of children and adults under 40 and more research is critical to improve outcomes for patients. We are delighted to become Plymouth University's official charity partner and look forward to working closely with staff, students and residents in the region to raise funds."

University of Plymouth

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to